Learn about the career of our Global Medical Affairs Head for Solid Tumors and Rare Diseases.

Explaining Chagas disease through the stories of patients in Bolivia.

Jennifer Allport-Anderson hunts for cardiac cures.

Make smart decisions about your research projects.

Novel PRC2 inhibitor changes the expression of hundreds of genes in lab model

A Cell & Gene production unit staffed by a highly trained team at Novartis will soon begin operating in Stein, Switzerland.

Research exploring the first visible changes in the brain is helping scientists evaluate new potential treatments for Alzheimer’s.

The most lethal strain could be eliminated by 2030, but major hurdles remain.